ADC Therapeutics SA Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
ADC Therapeutics SA (ADCT) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of -$11.09 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-10.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-03-10
- ADC Therapeutics SA effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was -$11.09M.
- ADC Therapeutics SA effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was -$12.22M.
- ADC Therapeutics SA effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was -$26.69M.
- ADC Therapeutics SA effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2022 was -$20.04M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month as first filed |
|---|---|---|
| 2025-12-31 | -$11.09M 10-K · filed 2026-03-10 | |
| 2024-12-31 | -$12.22M 10-K · filed 2026-03-10 | -$21.33M 10-K · filed 2025-03-27 |
| 2023-12-31 | -$26.69M 10-K · filed 2025-03-27 | |
| 2022-12-31 | -$20.04M 10-K · filed 2024-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |